# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-26-034858
Filing Date
2026-03-26
Accepted
2026-03-26 07:00:28
Documents
55
Period of Report
2026-03-20
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | tm269775d1_8k.htm iXBRL | 8-K | 29950
2 | EXHIBIT 3.1 | tm269775d1_ex3-1.htm | EX-3.1 | 144031
3 | EXHIBIT 99.1 | tm269775d1_ex99-1.htm | EX-99.1 | 558913
4 | EXHIBIT 99.2 | tm269775d1_ex99-2.htm | EX-99.2 | 61752
5 | GRAPHIC | tm269775d1_ex99-1img001.jpg | GRAPHIC | 2245
6 | GRAPHIC | tm269775d1_ex99-1img002.jpg | GRAPHIC | 25565
7 | GRAPHIC | tm269775d1_ex99-1img003.jpg | GRAPHIC | 63927
8 | GRAPHIC | tm269775d1_ex99-2img001.jpg | GRAPHIC | 62354
9 | GRAPHIC | tm269775d1_ex99-2img002.jpg | GRAPHIC | 368907
10 | GRAPHIC | tm269775d1_ex99-2img003.jpg | GRAPHIC | 140357
11 | GRAPHIC | tm269775d1_ex99-2img004.jpg | GRAPHIC | 135816
12 | GRAPHIC | tm269775d1_ex99-2img005.jpg | GRAPHIC | 88359
13 | GRAPHIC | tm269775d1_ex99-2img006.jpg | GRAPHIC | 135392
14 | GRAPHIC | tm269775d1_ex99-2img007.jpg | GRAPHIC | 185877
15 | GRAPHIC | tm269775d1_ex99-2img008.jpg | GRAPHIC | 107452
16 | GRAPHIC | tm269775d1_ex99-2img009.jpg | GRAPHIC | 105483
17 | GRAPHIC | tm269775d1_ex99-2img010.jpg | GRAPHIC | 44590
18 | GRAPHIC | tm269775d1_ex99-2img011.jpg | GRAPHIC | 176432
19 | GRAPHIC | tm269775d1_ex99-2img012.jpg | GRAPHIC | 122622
20 | GRAPHIC | tm269775d1_ex99-2img013.jpg | GRAPHIC | 126804
21 | GRAPHIC | tm269775d1_ex99-2img014.jpg | GRAPHIC | 131795
22 | GRAPHIC | tm269775d1_ex99-2img015.jpg | GRAPHIC | 122578
23 | GRAPHIC | tm269775d1_ex99-2img016.jpg | GRAPHIC | 77057
24 | GRAPHIC | tm269775d1_ex99-2img017.jpg | GRAPHIC | 52224
25 | GRAPHIC | tm269775d1_ex99-2img018.jpg | GRAPHIC | 123218
26 | GRAPHIC | tm269775d1_ex99-2img019.jpg | GRAPHIC | 122740
27 | GRAPHIC | tm269775d1_ex99-2img020.jpg | GRAPHIC | 133955
28 | GRAPHIC | tm269775d1_ex99-2img021.jpg | GRAPHIC | 122374
29 | GRAPHIC | tm269775d1_ex99-2img022.jpg | GRAPHIC | 132993
30 | GRAPHIC | tm269775d1_ex99-2img023.jpg | GRAPHIC | 70284
31 | GRAPHIC | tm269775d1_ex99-2img024.jpg | GRAPHIC | 40816
32 | GRAPHIC | tm269775d1_ex99-2img025.jpg | GRAPHIC | 111907
33 | GRAPHIC | tm269775d1_ex99-2img026.jpg | GRAPHIC | 203598
34 | GRAPHIC | tm269775d1_ex99-2img027.jpg | GRAPHIC | 178053
35 | GRAPHIC | tm269775d1_ex99-2img028.jpg | GRAPHIC | 121571
36 | GRAPHIC | tm269775d1_ex99-2img029.jpg | GRAPHIC | 173460
37 | GRAPHIC | tm269775d1_ex99-2img030.jpg | GRAPHIC | 148920
38 | GRAPHIC | tm269775d1_ex99-2img031.jpg | GRAPHIC | 190209
39 | GRAPHIC | tm269775d1_ex99-2img032.jpg | GRAPHIC | 141446
40 | GRAPHIC | tm269775d1_ex99-2img033.jpg | GRAPHIC | 114985
41 | GRAPHIC | tm269775d1_ex99-2img034.jpg | GRAPHIC | 131471
42 | GRAPHIC | tm269775d1_ex99-2img035.jpg | GRAPHIC | 115382
43 | GRAPHIC | tm269775d1_ex99-2img036.jpg | GRAPHIC | 34861
44 | GRAPHIC | tm269775d1_ex99-2img037.jpg | GRAPHIC | 411163
45 | GRAPHIC | tm269775d1_ex99-2img038.jpg | GRAPHIC | 172630
| Complete submission text file | 0001104659-26-034858.txt |  | 8323400

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
46 | XBRL TAXONOMY EXTENSION SCHEMA | hypd-20260320.xsd | EX-101.SCH | 3026
47 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | hypd-20260320_lab.xml | EX-101.LAB | 34239
48 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | hypd-20260320_pre.xml | EX-101.PRE | 22366
58 | EXTRACTED XBRL INSTANCE DOCUMENT | tm269775d1_8k_htm.xml | XML | 3335

Mailing Address 295 MADISON AVENUE SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE SUITE 2400 NEW YORK NY 10017 833-393-6684
HYPERION DEFI, INC. (Filer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38365 | Film No.: 26794290
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)